1. Anonymous (1988) DNA topoisomerases ? new twists to tumour therapy. Lancet I: 512
2. Beijnen JH, Smith BR, Keijer WJ, Van Gijn R, Ten Bokkel Huinink WW, Vlasveld LT, Rodenhuis S, Underberg WJM (1990) Highperformance liquid chromatographic analysis of the new antitumour drug SK&F 104864-A (NSC 609699) in plasma. J Pharm Biomed Anal 8: 789
3. Blaney SM, Balis FM, Cole DE, Craig C, Reid JM, Ames MM, Krailo M, Reaman G, Hammond D, Poplack DG (1993) Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res 53: 1032
4. Burris H, Kuhn J, Johnson R, Von Hoff D (1990) Preclinical studies of a new topoisomerase I inhibitor. Proc Am Assoc Clin Oncol 31: 431
5. Burris HA, Rothenberg ML, Kuhn JG, Von Hoff DD (1992) Clinical trials with the topoisomerase I inhibitiors. Semin Oncol 19: 663